Cargando...
Safety and efficacy of direct-acting antivirals for chronic hepatitis C in patients with chronic kidney disease
BACKGROUND: This is a real-world evidence study that aims to analyze the efficacy, tolerability and safety profile of paritaprevir/ombitasvir/ritonavir and dasabuvir, in patients with renal impairment. METHODS: We conducted an observational prospective study, on 232 patients with chronic kidney dise...
Guardado en:
| Publicado en: | BMC Nephrol |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BioMed Central
2020
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6966843/ https://ncbi.nlm.nih.gov/pubmed/31948406 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12882-020-1687-1 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|